Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2427857rdf:typepubmed:Citationlld:pubmed
pubmed-article:2427857lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0010068lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0019010lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0033497lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0055021lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2427857lifeskim:mentionsumls-concept:C0750491lld:lifeskim
pubmed-article:2427857pubmed:dateCreated1986-10-20lld:pubmed
pubmed-article:2427857pubmed:abstractTextThe acute hemodynamic effects of intravenously administered celiprolol and propranolol were compared in 18 patients, 12 with coronary obstruction in the presence or absence of reduced LV function and six with no significant cardiac disease. The study was performed using a single blind, randomized design with celiprolol (0.07 and 0.14 mg/kg) and propranolol (0.07 mg/kg) in six patients per treatment group. The hemodynamic parameters obtained via right and left heart catheterization were measured at baseline and at 5 and 10 min after drug infusion (1.0 mg/min). Propranolol produced a significant fall in left ventricular Vmax, left ventricular dP/dt and cardiac output. In contrast, celiprolol either caused no change or significantly increased these parameters. These results indicate that celiprolol has an acute hemodynamic profile which differs significantly from that of propranolol.lld:pubmed
pubmed-article:2427857pubmed:languageenglld:pubmed
pubmed-article:2427857pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427857pubmed:citationSubsetIMlld:pubmed
pubmed-article:2427857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427857pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2427857pubmed:statusMEDLINElld:pubmed
pubmed-article:2427857pubmed:issn0160-2446lld:pubmed
pubmed-article:2427857pubmed:authorpubmed-author:CarusoF SFSlld:pubmed
pubmed-article:2427857pubmed:authorpubmed-author:SolomonTTlld:pubmed
pubmed-article:2427857pubmed:authorpubmed-author:GensiniGGlld:pubmed
pubmed-article:2427857pubmed:authorpubmed-author:EsentePPlld:pubmed
pubmed-article:2427857pubmed:authorpubmed-author:DatorCClld:pubmed
pubmed-article:2427857pubmed:issnTypePrintlld:pubmed
pubmed-article:2427857pubmed:volume8 Suppl 4lld:pubmed
pubmed-article:2427857pubmed:ownerNLMlld:pubmed
pubmed-article:2427857pubmed:authorsCompleteYlld:pubmed
pubmed-article:2427857pubmed:paginationS83-5lld:pubmed
pubmed-article:2427857pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:meshHeadingpubmed-meshheading:2427857-...lld:pubmed
pubmed-article:2427857pubmed:year1986lld:pubmed
pubmed-article:2427857pubmed:articleTitleComparison of the acute hemodynamic effects of intravenous celiprolol and propranolol in patients with suspected coronary disease.lld:pubmed
pubmed-article:2427857pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2427857pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2427857pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2427857pubmed:publicationTypeRandomized Controlled Triallld:pubmed